Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0699790 (
colon cancer
)
28,837
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The resistance of transformed colon epithelial cells to immune system-mediated extrinsic apoptosis allows the development of fast growing
colon cancer
. Several tactics have been shown to clarify how colon adenocarcinomas avoid cell deletion and remain viable. Regardless of the presence of active membrane receptors, colorectal cancer cells resist interferon-mediated cell death. Similarly, they are refractory to TNF-alpha-dependent apoptosis. In our studies, we assumed that
IFN-R
and TNF-R1 receptors compete for STAT-1alpha kinase. Western blot and immunoprecipitation analyses were used to evaluate the protein to protein interactions. Cell viability was measured by MTT assay. We observed that STAT-1alpha kinase is bound to TRADD protein in TNF-R1 signalosome irrespective of the TNF-R1 bound ligand. The amount of STAT-1alpha kinase associated with TRADD was diminished after pretreatment with IFNs. IFN-alpha stimulated the survival of COLO 205 cells rather than promoted cell death. The latter was accompanied by NF-kappaB activation, a fact known to promote anti-apoptosis. STAT-1alpha renders colon adenocarcinoma COLO 205 cells less susceptible to TNF-alpha-induced apoptosis but IFN-alpha further extends the immune escape.
...
PMID:IFN-alpha competes with TNF-alpha for STAT-1alpha; molecular basis for immune escape of human colon adenocarcinoma COLO 205 cells. 1778 71